Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Early Detection and Targeted Treatments 2025 (arthritis | UK)

Versus Arthritis

We want to bring about more accurate and faster diagnosis and more timely, effective and targeted treatments, tailored to individuals, taking into consideration not just their genes but also the environment they live in. This call for applications for research funding focusses on two of the research priority areas from our Better Lives Today, Better Lives Tomorrow Research Strategy 2022-2026:

Early detection & prevention: spotting the biological signatures of arthritis early to maximise the opportunities for timely intervention and preventing it from getting worse
Targeted treatments: taking the guesswork out of treatment by increasing effective, reliable and timely drug and non-drug solutions to reduce, manage or cure disease

This call is emphasising our translational research agenda. We’re encouraging applications to push beyond gaining understanding the aetiology of arthritis. It must be clear from the application what the next step will be beyond the proposed study.

What are you looking for

The outcomes sought from this investment are progress toward:

better tools to identify markers of risk to enable proactive screening and early detection (secondary prevention) approaches
better tools and biomarkers to diagnose arthritis accurately and as rapidly as possible after symptoms begin
clinical and care pathways applying a precision medicine and holistic approach – accounting for individual variability in genes, environment and lifestyle and the management of pain, mental health and fatigue
more effective, safer treatments and ultimately cures, that work for more people
better tools to help decide the most appropriate treatments
more innovative approaches to how different diseases can be most effectively tackled together.

Specialties

Others

Rheumatology

Eligibility Requirements

The lead applicant must be based at an eligible UK institution.
One applicant must have a permanent position within the lead institute.

We welcome applications from fellows and lecturers who are looking to secure project support as a new investigator or mid-career researcher. Whilst there is no separate scheme or eligibility criteria, the panel will be asked to take career stage into account during the assessment process. 

Eligible Countries:

United Kingdom

Sponsor Details

Sponsor Institute/Organizations: Versus Arthritis

Sponsor Type:

Address: Versus Arthritis, Copeman House, St Mary's Court, St Mary's Gate, Chesterfield S41 7TD

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity